XML 38 R25.htm IDEA: XBRL DOCUMENT

Cash and Marketable Securities (Tables)

9 Months Ended

Sep. 30, 2025

Cash and Cash Equivalents [Abstract]

Summary of Reconciliation of Cash and Cash Equivalents

A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):


	September 30, 2025		September 30, 2024
Cash and cash equivalents	$	91,435	$	95,400
Restricted cash	551		592
Total cash, cash equivalents and restricted cash at the end of the period	$	91,986	$	95,992

Summary of Marketable Securities

The amortized cost, unrealized holding gains and losses and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):


	September 30, 2025
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
Short-term marketable securities:
U.S. agency securities	$	82,805	$	822	$	—	$	83,627
Corporate debt securities	19,977		145		—		20,122
Total short-term marketable securities	$	102,782	$	967	$	—	$	103,749


	December 31, 2024
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
Short-term marketable securities:
U.S. agency securities	$	90,918	$	1,652	$	(4)	$	92,566
Corporate debt securities	55,046		718		—		55,764
Total short-term marketable securities	$	145,964	$	2,370	$	(4)	$	148,330